The Biotin-conjugated CACNA1C antibody is validated for diverse techniques:
Detects Cav1.2 in lysates (e.g., rat brain) at 1 μg/ml concentration .
Used to study protein expression levels and post-translational modifications.
Identifies Cav1.2 localization in tissue sections (e.g., cardiac or neuronal tissues).
Compatible with formalin-fixed, paraffin-embedded (FFPE) samples .
Isolates Cav1.2 for downstream analysis (e.g., interaction studies) .
Requires secondary antibodies (e.g., HRP-conjugated anti-mouse IgG).
Visualizes Cav1.2 distribution in live or fixed cells (e.g., HEK293 or INS-1E cells) .
Compatible with fluorescence microscopy.
The antibody aids in studying CACNA1C mutations linked to cardiac disorders:
In HEK293 cells, Pro857Arg-CACNA1C mutations increase peak calcium currents (I<sub>Ca,L</sub>) by 113% and surface expression by 64% .
Detects Cav1.2 in human, mouse, rat, and hamster samples, making it suitable for comparative studies .
WB: 1 μg/ml concentration detects Cav1.2 in 10 μg rat brain lysate .
IHC/IF: Effective at 1:100 dilution for fluorescence-based imaging .
Glycosylation Variability: Observed band size (~240 kDa) may shift due to post-translational modifications .
Cross-Reactivity: Ensure species-specific validation (e.g., rabbit reactivity confirmed) .
| Feature | CACNA1C Antibody, Biotin Conjugated (ABIN2485656) | Other Conjugates (e.g., PE, HRP) |
|---|---|---|
| Conjugate | Biotin | Fluorophores, Enzymes |
| Detection Method | Avidin/streptavidin-based systems | Direct fluorescence or enzymatic |
| Applications | WB, IHC, IP, IF, ICC, AA | Flow cytometry, ELISA |
| Sensitivity | High (via signal amplification) | Moderate to high |
| Flexibility | Compatible with multiple detection formats | Limited to specific techniques |